Across TCGA pan-cancer cohorts, SWSAP1 Mutation is linked to patient survival in 3 of 34 cancer types, making it a survival-associated SWSAP1 data layer compared with 22 for mass-spec protein and 2 for mass-spec protein.
The strongest signal is observed in thyroid carcinoma (THCA), where higher SWSAP1 Mutation is associated with worse disease-free survival. In most high-consensus cancer types, elevated SWSAP1 expression acts as an unfavorable survival marker.
THCA, BLCA, and SKCM are the cancer types where SWSAP1 Mutation most reproducibly stratifies survival.